Skip Navigation


Bioinformatics Advance Access originally published online on May 29, 2008
Bioinformatics 2008 24(14):1639-1640; doi:10.1093/bioinformatics/btn251
This Article
Right arrow Full Text
Right arrow Full Text (Print PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
24/14/1639    most recent
btn251v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thurmond, J.
Right arrow Articles by Fischer, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thurmond, J.
Right arrow Articles by Fischer, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Web-based design and evaluation of T-cell vaccine candidates

James Thurmond 1,{dagger}, Hyejin Yoon 1,{dagger}, Carla Kuiken 1, Karina Yusim 1, Simon Perkins 2, James Theiler 1, Tanmoy Bhattacharya 1,3, Bette Korber 1,3 and Will Fischer 1,*

1Los Alamos National Laboratory, Los Alamos, NM 87545, 2UltraSpectral Inc., 5701 Carmel Ave. NE, Suite C, Albuquerque NM 87113 and 3The Santa Fe Institute, Santa Fe, NM 87501, USA

*To whom correspondence should be addressed.


  Abstract

Summary: We present a suite of on-line tools to design candidate vaccine proteins, and to assess antigen potential, using coverage of k-mers (as proxies for potential T-cell epitopes) as a metric. The vaccine design tool uses the recently published ‘mosaic’ method to generate protein sequences optimized for coverage of high-frequency k-mers; the coverage-assessment tools facilitate coverage comparisons for any potential antigens. To demonstrate these tools, we designed mosaic protein sets for B-clade HIV-1 Gag, Pol and Nef, and compared them to antigens used in a recent human vaccine trial.

Availability: http://hiv.lanl.gov/content/sequence/MOSAIC/

Contact: wfischer{at}lanl.gov

Supplementary information: Supplementary data are available at ftp://ftp-t10.lanl.gov/pub/btk/WebToolsData

Associate Editor: Alfonso Valencia

{dagger}The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.

Received on January 7, 2008; revised on May 8, 2008; accepted on May 28, 2008

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.